Seaport Therapeutics, Inc. (SPTX) Income Statement

32 Followers

Seaport Therapeutics, Inc. Income Statement

Last quarter (Q2 2026), Seaport Therapeutics, Inc.'s total revenue was $0.00, a decrease of ― from previous quarter. In Q2, Seaport Therapeutics, Inc.'s net income was $-62.60M. See Seaport Therapeutics, Inc.’s key income statements, including revenue, expenses, profit, and income.

Income Statement	Dec 25
Total Revenue	$ 0.00
Gross Profit	$ 0.00
Operating Expenses	$ 87.29M
Depreciation and Amortization	$ 1.41M
EBITDA	$ -85.89M
Operating Income	$ -87.29M
Other Income/Expenses	$ 13.19M
Pretax Income	$ -74.11M
Net Income	$ -74.88M
Per Share Metrics
Basic EPS	$ -1.94
Diluted EPS	$ -1.94
Weighted Average Shares Outstanding	38.65M
Weighted Average Shares Outstanding (Diluted)	38.65M

Currency in USD

Seaport Therapeutics, Inc. (SPTX) Income Statement

Seaport Therapeutics, Inc. Income Statement

Seaport Therapeutics, Inc. Earnings and Revenue History